-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803. Emerging Diagnostic Tools and Techniques: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 13, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Linda Yingqi Lin1*, Samuele Cancellieri, MS2*, Jing Zeng, MD1*, Francesco Masillo, BSc2*, My Anh Nguyen, MS1*, Nicola Bombieri, PhD2*, Stacy A. Maitland3*, Marioara-Felicia Ciuculescu, MD4*, Varun Katta5*, Shengdar Q. Tsai, PhD5, Myriam Armant, PhD4*, Scot A. Wolfe, PhD3*, Rosalba Giugno, PhD2*, Luca Pinello, PhD6* and Daniel E. Bauer, MD, PhD1

1Department of Pediatric Hematology/Oncology, Boston Children’s Hospital, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Broad Institute, Harvard Medical School, Boston, MA
2Department of Computer Science, University of Verona, Verona, Italy
3Department of Molecular, Cell and Cancer Biology, Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, MA
4TransLab, Boston Children's Hospital, Boston, MA
5Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
6Molecular Pathology Unit, Center for Cancer Research, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Hyunjun Nam1*, Christophe Magnan, PhD1*, Fernando Lopez-Diaz, PhD1*, Ryan Bender, PhD, FACMGG1*, Sally Agersborg, MD, PhD2*, Segun C Jung, PhD2* and Vincent Funari, PhD2

1NeoGenomics Laboratories, Inc., Carlsbad, CA
2NeoGenomics Laboratories, Inc., Aliso Viejo, CA

Wolfgang Kern, MD1, Theresia M. Westers, PhD2*, Frauke Bellos, MD1*, Marie C Bene, PharmD, DPhil3*, Peter Bettelheim, MD4*, Lisa Eidenschink Brodersen, PhD5, Kate Burbury, MBBS, FRACP, FRCPA, DPhil6*, Sung-Chao Chu7*, Matthew Cullen, MSc8*, Matteo Della Porta9*, Alan Stewart Dunlop, MSc, BS10*, Ulrika Johansson11*, Sergio Matarraz12*, Uta Oelschlaegel, PhD13*, Kiyoyuki Ogata, MD14, Anna Porwit, MD, PhD15*, Frank W. M. B. Preijers16*, Katherina Psarra17*, Leonie Saft, MD, PhD18*, Dolores Subirá, MD, PhD19*, Elisabeth Weiss, PhD1* and Arjan A. Van de Loosdrecht, MD, PhD20

1MLL Munich Leukemia Laboratory, Munich, Germany
2Department of Hematology, Amsterdam University Medical Center, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands
3Hematology Biology, Nantes University Hospital, Nantes, France
4Elisabethinen Hospital, Linz, Upper Austria, Austria
5Hematologics, Inc., Seattle, WA
6Peter MacCallum Cancer Centre, Melbourne, Australia
7Buddhist Tzu Chi General Hospital, Hualien, TWN
8St James's University Hospital, Leeds, GBR
9IRCCS Humanitas Research Hospital & Department of Biomedical Sciences, Humanitas University, Milan, Italy
10Immunophenotyping, Royal Marsden Hospital, Sutton, ENG, United Kingdom
11Laboratory Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
12Cytometry Service (NUCLEUS), Department of Medicine and IBSAL, Cancer Research Center (IBMCC, University of Salamanca-CSIC), Salamanca, Spain and Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain
13University Hospital of Technical University Dresden, Dresden, Saxony, Germany
14Shin-Yurigaoka General Hospital, Tokyo, JPN
15Division of Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden
16Department of laboratory medicine – laboratory of hematology, Radboudumc, Nijmegen, Netherlands
17Immunology Histocompatibility Department, Evangelismos Hospital, Athens, Greece
18Department of Pathology,, Karolinska University Hospital, Solna, Stockholm, Sweden
19Hospital Universitario de Guadalajara, Guadalajara, Spain
20Department of hematology, Amsterdam UMC, Amsterdam, Netherlands

Serageldin Kamel, MBBCh1, Li-Wei Chen, Msc2*, Gregory Ravizzini, MD3*, Ho-Feng Chen2*, Joo Schmidt1*, Sairah Ahmed, MD1,4, Ranjit Nair, MD1*, Raphael E Steiner, MD1, Branko Cuglievan, MD5*, Yago Nieto, MD6,7, Roberto N. Miranda, MD8*, Penny Fang, MD9*, Jillian R. Gunther, MD, PhD9*, Chelsea C. Pinnix, MD, PhD10, Michael Wang, MD1,7, Tinsu Pan, PhD11* and Hun Lee, MD12

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biomedical Engineering, National Taiwan University, Taipei, Taiwan
3Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
5Division of Pediatric Hematology Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX
9Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX
11Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX
12Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Michael Laurence Langsen1*, Jerry Thwin Wong, MD, PhD2, Maximilian Merz, MD3,4*, Brian Yu5,6*, Hemn Mohammadpour, PhD7, Philip L. McCarthy, MD8 and Jens Hillengass5

1Medical Physics program, Jacobs School of Medicine, University at Buffalo, The State University of New York, Buffalo, NY
2Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
3University of Heidelberg, Heidelberg, Germany
4Roswell Park Comprehensive Cancer Center Institute, Buffalo, NY
5Roswell Park Comprehensive Cancer Center, Buffalo, NY
6Jacobs School of Medicine, University at Buffalo, The State University of New York, Buffalo, NY
7Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
8Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY

Lei-Ming Cao1*, Li-Xin Wu1*, Ming-Yue Zhao1*, Ya-Lan Zhou1*, Jin-Lan Li1*, Qiu-Yu Sun1*, Hao Jiang1*, Jiang Qian, MD1, Lan-Ping Xu1*, Xiao-Hui Zhang1*, Kai-Yan Liu1, Xiao-Jun Huang1,2,3* and Guo-Rui Ruan1*

1Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
2Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China
3Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China

Ben Zion Katz, PhD1,2, Shahar Karni, MSc3*, Hadar Shimoni4*, Amit Natan4*, Amir Shaham4*, Dan Benisty, MD5*, Olga Pozdnyakova, MD, PhD6*, Merav Barzilai, MD1,7*, Moshe Mittelman, MD1,8 and Irit Avivi, MD9,10*

1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Hematology, Tel Aviv Soursky Medical Center, Tel Aviv, AL, ISR
3Scopio Labs, Tel Aviv, ISR
4Scopio Labs, Tel Aviv, Israel
5Hematology, Tel Aviv Medical Center, Tel Aviv, Israel
6Department of Pathology, Brigham and Women's Hospital, Boston, MA
7Institute of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
8Department of Internal Medicine A, Tel Aviv Sourasky (ichilov) Medical Center, Tel Aviv, Israel
9BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Aviv, Israel
10Sackler Faculty of Medicine, Tel Aviv, Israel

Adam Bagg, MD1, Philipp Raess, MD2*, Deborah Rund, MD3*, Darrin Jengehino4*, Joanna Wiszniewska, MD2*, Michelle Huynh4*, Abdoulaye Sanogo4*, Alon Horowitz, MD5*, Guang Fan, MD, PhD6, Siddharth Bhattacharyya, MD4*, Irit Avivi, MD7,8* and Ben Zion Katz, PhD9,10

1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
2Oregon Health & Science University, Portland, OR
3Hadassah University Hospital, Jerusalem, ISR
4University of Pennsylvania Hospital, Philadelphia, PA
5Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
6Department of Pathology, Oregon Health and Science University, Portland, OR
7BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Aviv, Israel
8Sackler Faculty of Medicine, Tel Aviv, Israel
9Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
10Hematology, Tel Aviv Soursky Medical Center, Tel Aviv, AL, ISR

Lindsey A. Murphy, MD, Russell Marians, PhD*, Mark Eric Kohler, MD, PhD, Terry J. Fry, MD and Amanda C. Winters, MD, PhD

University of Colorado Anschutz Medical Campus, Aurora, CO

Shrutii Sarda, PhD, MS1*, Geoffrey Lowman, PhD2*, Michelle Toro, MS3*, Loni Pickle3*, Timothy Looney, PhD4 and Fiona Hyland1*

1Thermo Fisher Scientific, South San Francisco, CA
2ThermoFisher Scientific, CARLSBAD, CA
3Thermo Fisher Scientific, Carlsbad, CA
4Thermo Fisher Scientific, AUSTIN, TX

Augusta Eduafo, DO1*, Leland Metheny III, MD2, Ravi Kyasaram3*, Farhad Sanati4*, James J. Driscoll, MD, PhD5 and Ehsan Malek, MD6

1Internal Medicine Department, St. John Medical Center, Westlake, OH
2Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
3University Hospitals Cleveland Medical Center, Cleveland, OH
4University Hospitals Cleveland Medical Centers, Cleveland, OH
5Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
6Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH

Jean-Francois Rossi, MD1,2, Hao-Chun Chiang, PhD3*, Zhao-Yang Lu, PhD4*, Kalle Levon, PhD3*, Frits van Rhee, MD PhD5, Karan Kanhai6*, David C Fajgenbaum, MD, MBA, MSc7,8 and Bernard Klein, MD1*

1Faculté de Médecine Montpellier, Université de Montpellier, Montpellier, France
2Hématologie-Immunothérapie, Institut du Cancer Avignon-Provence, Sainte Catherine, France
3Department of Chemical and Biomolecular Engineering, NYU Tandon School of Engineering., NY, NY
4Unité de Thérapie Cellulaire, CHU Montpellier Saint-Eloi, Montpellier, France
5Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
6Medical Affairs, EUSA Pharma, Hemel Hempstead, United Kingdom
7Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
8Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Maren Schmiester1,2*, René Maier3*, René Riedel, PhD3*, Marco Frentsch, PhD4*, Robert R. Jenq, MD5, Christine B. Peterson, PhD6*, Liangliang Zhang, PhD6*, Lars Bullinger7,8,9, Hyun-Dong Chang, PhD3,10* and Il-Kang Na, MD1,4,8,11*

1Department of Hematology, Oncology, and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
2Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
3Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute (DRFZ), Berlin, Germany
4BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
5Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
7German Cancer Research Center (DKFZ), Heidelberg, Germany
8German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany
9Department of Hematology, Oncology and Tumor Immunology, Campus Virchow, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
10Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany
11Experimental and Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Tukten Rolfe, MBBS, BSc1*, Quirine O'Loughlin2*, Heather Campbell2*, Jordan Barr2*, Fiona Shawyer2* and Teng Fong Ng, BSc, MBBS, MRCP1

1Gold Coast University Hospital, Southport, QLD, Australia
2Pathology Queensland, Southport, QLD, Australia

Valentin Clichet1*, Véronique Harrivel, MD2*, Caroline Delette, MD3,4*, Eric Guiheneuf, PharmD2*, Murielle Gautier2*, Pierre Morel, MD5*, Deborah Assouan, MD3*, Lavinia Merlusca, MD6*, Marie Beaumont, MD4*, Delphine Lebon6*, Alexis Caulier, MD PhD7*, Jean-Pierre Marolleau, MD, PhD3, Thomas Matthes, MD8, Francois Vergez, DVM, PhD9*, Loïc Garçon, MD PhD2* and Thomas Boyer2*

1Laboratoire d'Hématologie, CHU Amiens, Amiens, FRA
2Laboratoire d'Hématologie, CHU Amiens, Amiens, France
3Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens, Amiens, France
4Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens, Amiens, FRA
5Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens, Salouel, France
6Hematology department, CHU Amiens, Amiens, France
7Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens, Amiens, France, FRA
8Service d’Hématologie, Université de Genève, Onex, Switzerland
9Hematology Biology, Centre Hospitalo-universitaire (CHU) de Toulouse, Centre de Recherches en Cancérologie de Toulouse (CRCT), Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Université de Toulouse, UPS, INSERM, TOULOUSE, FRA

*signifies non-member of ASH